Department of Pediatrics, Section of Hematology/Oncology/Bone Marrow Transplantation, University of Colorado-Denver and Children's Hospital Colorado, Aurora, CO 80045-0507, USA.
Haematologica. 2012 Apr;97(4):509-15. doi: 10.3324/haematol.2011.054775. Epub 2011 Dec 1.
Studies evaluating risk factors for in-hospital venous thromboembolism in children are limited by quality assurance of case definition and/or lack of controlled comparison. The objective of this study is to determine risk factors for the development of in-hospital venous thromboembolism in children.
In a case-control study at The Children's Hospital, Colorado, from 1(st) January 2003 to 31(st) December 2009 we employed diagnostic validation methods to determine pediatric in-hospital venous thromboembolism risk factors. Clinical data on putative risk factors were retrospectively collected from medical records of children with International Classification of Diseases, 9th edition codes of venous thromboembolism at discharge, in whom radiological reports confirmed venous thromboembolism and no signs/symptoms of venous thromboembolism were noted on admission.
We verified 78 cases of in-hospital venous thromboembolism, yielding an average incidence of 5 per 10,000 hospitalized children per year. Logistical regression analyses revealed that mechanical ventilation, systemic infection, and hospitalization duration of five days or over were statistically significant, independent risk factors for in-hospital venous thromboembolism (OR=3.29, 95%CI=1.53-7.06, P=0.002; OR=3.05, 95%CI=1.57-5.94, P=0.001; and OR=1.03, 95%CI=1.01-1.04, P=0.001, respectively). Using these factors in a risk model, post-test probability of venous thromboembolism was 3.6%.
These data indicate that risk of in-hospital venous thromboembolism in children with this risk factor combination may exceed that of hospitalized adults in whom prophylactic anticoagulation is indicated. Substantiation of these findings via multicenter studies could provide the basis for future risk-stratified randomized control trials of pediatric venous thromboembolism prevention.
评估儿童住院期间静脉血栓栓塞风险的研究受到病例定义质量保证和/或缺乏对照比较的限制。本研究的目的是确定儿童住院期间静脉血栓栓塞形成的危险因素。
在科罗拉多州儿童医院的一项病例对照研究中,我们于 2003 年 1 月 1 日至 2009 年 12 月 31 日采用诊断验证方法确定儿科住院期间静脉血栓栓塞的危险因素。从出院时国际疾病分类第 9 版静脉血栓栓塞代码的患儿病历中回顾性收集疑似危险因素的临床数据,放射学报告证实静脉血栓栓塞,入院时无静脉血栓栓塞的体征/症状。
我们验证了 78 例住院期间静脉血栓栓塞病例,每年每 10000 名住院患儿的平均发病率为 5 例。逻辑回归分析显示,机械通气、全身感染和住院时间为 5 天或以上是静脉血栓栓塞的统计学上显著的独立危险因素(OR=3.29,95%CI=1.53-7.06,P=0.002;OR=3.05,95%CI=1.57-5.94,P=0.001;OR=1.03,95%CI=1.01-1.04,P=0.001)。在风险模型中使用这些因素,静脉血栓栓塞的后验概率为 3.6%。
这些数据表明,具有这种危险因素组合的儿童住院期间静脉血栓栓塞的风险可能超过需要预防性抗凝治疗的住院成人。通过多中心研究证实这些发现可为未来儿科静脉血栓栓塞预防的风险分层随机对照试验提供依据。